Applying machine learning to high-dimensional proteomics datasets for the identification of Alzheimer's disease biomarkers.
Journal:
Fluids and barriers of the CNS
PMID:
40033432
Abstract
PURPOSE: This study explores the application of machine learning to high-dimensional proteomics datasets for identifying Alzheimer's disease (AD) biomarkers. AD, a neurodegenerative disorder affecting millions worldwide, necessitates early and accurate diagnosis for effective management.